New Zealand markets close in 2 hours 4 minutes

NVS Jan 2025 100.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
11.150.00 (0.00%)
As of 09:31AM EDT. Market open.
Full screen
Previous close11.15
Expiry date2025-01-17
Day's range11.10 - 11.16
Contract rangeN/A
Open interest205
  • Zacks

    FDA Accepts Merck (MRK) sNDA for Welireg in Renal Cell Carcinoma

    The FDA filing is supported by data from a late-stage study that shows that Merck's (MRK) Welireg achieved statistically significant and clinically meaningful improvement in progression-free survival.

  • Zacks

    Novartis' (NVS) Shareholders Approve Sandoz Separation

    Novartis' (NVS) shareholders vote in favor of the 100% spin-off of Sandoz into a new publicly traded standalone company.

  • GlobeNewswire

    Sandoz receives positive CHMP opinion for breast and gastric cancer biosimilar trastuzumab

    Positive CHMP opinion based on comprehensive package of analytical, pre-clinical and clinical dataBreast and gastric cancers are among most common types of cancer, accounting together for nearly half a million new cases every year in Europe alone1,2Sandoz is committed to accelerating access to potentially life-changing treatments and continues to strengthen its oncology and supportive care portfolioBasel, September 18, 2023 — Sandoz, a global leader in generic and biosimilar medicines, today ann